CARTO VIZIGO™ Bi-Directional Guiding Sheath
The CARTO VIZIGO™ Bi-Directional Guiding Sheath puts electrophysiologists in command for the ultimate CARTO™ 3 System experience. Confidence in procedures with sheath visualization, efficiencies and optimized performance.
The VIZIGO™ Sheath allows for sheath visualization on the CARTO™ 3 System map during a procedure without depending solely on fluoroscopy. Visualization with the CARTO VIZIGO™ Bi-Directional Guiding Sheath may enhance efficiency during mapping and positioning of the ablation catheter.
.png?width=3840&quality=90&format=webp)
.png?width=3840&quality=90&format=webp)
Features & benefits
.png?width=3840&quality=90&format=webp)
Visualization
The VIZIGO™ Sheath allows for sheath visualization on the CARTO™ 3 System map during a procedure without depending solely on fluoroscopy.
.png?width=3840&quality=90&format=webp)
Efficiency
- Sheath visualization aids in understanding the spatial relationship between the catheter and the sheath during navigation1
- Sheath visualization also aids in understanding the orientation during catheter manipulation
.png?width=3840&quality=90&format=webp)
Performance
- Braided shaft with silicone coating to enable good torque and friction response
- Ergonomic handle design
An integrated system
.png?width=3840&quality=90&format=webp)
VARIPULSE™ Platform
.png?width=3840&quality=90&format=webp)
OCTARAY™ Mapping Catheter with TRUEref™ Technology
.png?width=3840&quality=90&format=webp)
CARTO™ System Software
.png?width=3840&quality=90&format=webp)
OPTRELL™ Mapping Catheter with Multipolar Technology
.png?width=3840&quality=90&format=webp)
QDOT MICRO™ Catheter
References
- Wakamatsu Y, et al. Impact of the combined use of intracardiac ultrasound and a steerable sheath visualized by a 3D mapping system on pulmonary vein isolation. Pacing Clin Electrophysiol. 2021 Apr;44(4):693-702. doi: 10.1111_pace.14194. Epub 2021 Mar 11. PMID: 33595100.
DO NOT use OCTARAY™ or OPTRELL™ Mapping Catheters with TRUEref™ Technology in patients with prosthetic valves.
The Johnson & Johnson and its affiliates QDOT MICRO™ Catheters and related accessory devices are indicated for catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used in conjunction with a compatible radiofrequency generator, for the treatment of:• Type I atrial flutter in patients age 18 or older.• Drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems.The Johnson & Johnson and its affiliates QDOT MICRO™ Catheters provide real-time measurement of contact force between the catheter tip and heart wall, as well as location information when used with CARTO™ 3 Navigation System.
Always verify catheter tip location using common clinical practice for real-time verification (inspection of IC signals, direct imaging guidance such as fluoroscopy or ultrasound, etc.) and consult the CARTO™ 3 System User Guide regarding recommendations for fluoroscopy use.
Canpolat, U. et al (2020). State of Fluoroless Procedures in Cardiac Electrophysiology Practice. J Innov Cardiac Rhythm Management. 11(3), 4018–4029.Sommer, P. et al (2018) Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures, EP Europace, Volume 20, Issue 12, Pages 1952–1958.
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician.
This site is published by Johnson & Johnson and its affiliates, which is solely responsible for its contents. It is intended for visitors from the United States. Last Updated on 09/15/2025.
US_ELP_ACSS_407859